Mortality Rates from Cancer or All Causes and SOD Activity Level and Zn/Cu Ratio in Peripheral Blood: Population-based Follow-up Study
Autor: | Motohiko Otani, Yoshinori Ito, Ryuichiro Sasaki, Kunio Aoki, Koji Suzuki |
---|---|
Rok vydání: | 2002 |
Předmět: |
Adult
Male Rural Population Lipid Peroxides medicine.medical_specialty Epidemiology Physiology Superoxide dismutase Japan Cause of Death Neoplasms medicine TBARS Humans Proportional Hazards Models Cause of death Analysis of Variance biology Superoxide Dismutase Proportional hazards model business.industry Mortality rate Hazard ratio Cancer General Medicine Middle Aged medicine.disease Surgery Zinc Cohort biology.protein Female business Copper Follow-Up Studies |
Zdroj: | Journal of Epidemiology. 12:14-21 |
ISSN: | 0917-5040 |
DOI: | 10.2188/jea.12.14 |
Popis: | A total of 507 residents (232 males and 275 females) of a rural area of Hokkaido, Japan, were enrolled in the present follow-up study as the follow-up cohort. We investigated the relationship between mortality rates from cancer or all causes and blood levels of SOD activity and Zn/Cu ratio, and serum levels of SOD activity and lipid peroxides (TBARS), by following up our subjects over the course of 18 years. The hazard ratios of lowest blood levels of SOD activity and Zn/Cu ratios to mortality rates from cancer were 1.36 (95% C.I.: 0.59-3.10) and 1.97 (95% C.I.: 0.84-4.63), and those to mortality rates from all causes were 1.31 (95%C.I: 0.76-2.27) and 1.99 (95%C.I.: 1.14-3.46), respectively, in comparison with subjects with highest values for these factors. Hazard ratios of lowest serum levels of SOD activity and TBARS to mortality rates from cancer were 2.68 (95%C.I.: 1.05-6.82) and 0.71 (95%C.I.: 0.31-1.67), and those to mortality rates from all causes were 1.55 (95% C.I., 0.90-2.66) and 0.88 (95%C.I.: 0.51-1.50), respectively. The results of this follow-up study indicate that high serum SOD activity is associated with protective effects against mortality from cancer, and that high blood Zn/Cu ratio is associated with low mortality from other causes. In contrast, serum TBARS levels do not appear to be a biomarker for the risk of death from cancer. |
Databáze: | OpenAIRE |
Externí odkaz: |